LYMESEQ

Welcome to the Brand page for “LYMESEQ”, which is offered here for Diagnostic reagents for laboratory use, for clinical, medical, or epidemiological laboratory use; chemical preparations for scientific purposes; reagents for use in scientific apparatus for chemical or biological analysis; testing kits containing reagents used in analyzing and detecting certain microorganisms for clinical, medical, or epidemiological laboratory use; microbiological genetic identity tests comprised of reagents for scientific research; biomedical compounds, substrates used in analyzing and detecting certain nucleic acids for laboratory or research use; chemical preparations to be used in biochemical and clinical research; diagnostic preparations for laboratory use in science, for clinical, medical, or epidemiological laboratory use; medical diagnostic reagents for the analysis of body fluids; microbiological genetic identity tests for medical purposes comprised of reagents; diagnostic preparations for laboratory use, for medical use; clinical medical reagents; diagnostic kits for medical use, comprised of medical diagnostic reagents and assays for testing blood and other body fluids or microbiological specimens; diagnostic preparations for medical purposes; testing kits comprised of medical diagnostic reagents and assays for testing bodily fluids or microbiological specimens; medical diagnostic test kits comprised of reagents and assays for testing of body fluids or microbiological specimens; computer software for healthcare monitoring, monitoring healthcare-acquired infections or community-acquired infections; computer software for medical diagnostics testing and monitoring and for communicating medical test results to patients and service providers in the medical and healthcare fields; computer software for medical monitoring and analysis of medical data; computer software for controlling the operation of medical equipment and test results; computer software for analysis of body fluids; computer software for communication and data transfer between testing facilities and health care professionals; mobile electronic devices, personal digital assistants, tablet computers, mobile phones, laptop computers, and smartphones; laboratory apparatus, for use in medical laboratories, for analysis of body fluids and tissue; medical and scientific research in the field of microbiological testing and diagnosis and treatment of medical conditions; development and laboratory testing in the field of microbiological-caused human disease; scientific research consulting in the field of microbiological-based genetics, genomics, dna sequencing, and bioinformatics; genetic research, development and testing services; genomic research, development and testing services for scientific research purposes; dna collection, testing and analysis services for scientific research purposes; genetic testing for scientific research purposes; genomic testing for scientific research purposes; medical and scientific research, development and consulting in the field of infectious diseases; medical and scientific research in the field of genetics and genetic engineering; medical and scientific research and consulting in the fields of genomics and next generation sequencing; medical and scientific research in the field of infectious disease diagnosis epidemiology; data collection for research purposes, the collection, testing and research of patient specimen molecular and/or genomic data; compiling genomic data for research purposes in the field of medical science; dna-sequencing for scientific research purposes; genotyping; gene screening; consulting services in the field of microbiology; medical and scientific research services in the field of health care; scientific research consulting services in the fields of biotechnology, laboratory testing, diagnostics, hospital-acquired and community-acquired infections, and antibiotic-resistant organisms; biological research; biomedical research; laboratory research in the field of microbiology, biochemistry, biology, health and medicine; medical laboratories; medical laboratory services; providing laboratory research services in the field of gene expression, disease biology; scientific laboratory services; software as a service (saas) for medical and disease analysis; medical testing for diagnostic or treatment purposes in the field of infectious diseases; medical diagnostic testing, monitoring and reporting services; medical evaluation services, for evaluation of presence of infectious diseases; medical monitoring services; medical diagnostic, prognostic and theranostic screening and testing, determination of antibiotic resistance of microorganisms; collection and preservation of dna for medical and research purposes; consulting services in the nature of providing medical information; consulting services in the field of healthcare, insurance reimbursement, and microbiology; genetic testing for scientific diagnostic purposes; genomic testing for scientific diagnostic purposes; genotype-based testing for medical purposes; providing information in the field of infectious disease prevention, screening, diagnosis and treatment for medical diagnostic and treatment purposes; microbiological screening for medical diagnostic purposes; medical care consulting services in the fields of biotechnology, laboratory testing, diagnostics, hospital-acquired and community-acquired infections, and antibiotic-resistant organisms; consulting services in the nature of providing information about medical services; consulting services in the field of insurance reimbursement; consulting services in the nature of providing information about insurance reimbursement; consulting services in the field of medical education, providing education and training information relating to the identification, diagnosis and treatment of medical conditions, including healthcare-acquired infections or community-acquired infections; education services, providing live and on-line continuing professional education seminars in the medical, scientific and insurance field; educational services, seminars and educational conventions;.

Its status is currently believed to be active. Its class is unavailable. “LYMESEQ” is believed to be currently owned by “The Translational Genomics Research Institute”.